The problem of viral resistance in chronic hepatitis B therapy
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2009, Vol 26, Issue 3
Abstract
Available agents for the treatment of chronic HBV infection include interferon-alpha, the nucleoside analogues lamivudine, telbivudine, entecavir and the noucleotide analogue adefovir and tenofovir. When nucleoside-nucleotide analogues are used, patients require a long duration of treatment, especially in HBeAg negative disease, with the potential for developing antiviral resistance, which limits their long-term effectiveness. Interferon-alpha lacks viral resistance selection. Resistance rates vary by compound. Lamivudine is associated with the development of viral resistance in up to 70% within 5 years, adefovir dipivoxil in 29% after 5 years, entecavir in <1% in naive patients for up to 4 years (39% in 4 years in lamivudine-resistant patients) and telbivudine in 22% after 2 years of therapy. Clinical consequences of nucleoside-noucleotide resistance include loss of viral response (i.e., a rise in serum HBV DNA), biochemical dysfunction with an increase in aminotransferases, and overt hepatic failure (in patients with more advanced underlying liver disease). The initial choice of antiviral agent should take into consideration both the potency and the incidence of resistance, with serial HBV DNA determination to confirm adequate viral suppression. A suboptimal response to therapy with continued high-level replication identifies a patient at high risk for viral resistance, and is an indication for a change in antiviral strategy. Routine on-treatment monitoring of HBV DNA levels is imperative for detecting virologic breakthrough as early as possible, and for transitioning patients to rescue therapy before biochemical failure and loss of response occurs. For lamivudine resistant HBV infection, adefovir or tenofovir, and for adefovir resistance lamivudine should be added. In conclusion, monitoring for drug resistance during therapy and its prompt management are crucial in managing the antiviral treatment of HBV patients.
Authors and Affiliations
S. DOURAKIS
Keywords
Related Articles
- EP ID EP160128
- DOI -
- Views 63
- Downloads 0
Occupational cancer in Greece
OBJECTIVE This report includes information about occupational cancer and presents estimates for the numbers of new cases and deaths in Greece that could be attributed to occupational exposures. METHOD In order to esti...
The mentally ill as a "spectacle" on the streets of Athens <br /> <br />
The history of psychiatry, as well as its achievements and progress, includes also some dark pages, when the mentally ill were demonstrated as a spectacle in the hospitals and the outpatient departments, and those wander...
Reporting of errors and patient safety: The correct approach to faults and the role of the legal context of medical liability
Medical errors and adverse events occur in all healthcare systems worldwide. Medical errors are very often caused by systemic factors and for this reason error reporting and analysis systems have started to be developed...
Hypokalemia and nephrolithiasis/nephrocalcinosis are the main findings in proximal RTA type II
No abstract available
Τhe effect of a specific exercise program on the lipid profile<br /> and fitness of postmenopausal women
OBJECTIVE To examine the effects of a specific exercise program on the lipid profile and fitness in healthy, early postmenopausal women (